• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Pfizer, Glaxo, Novo, Novartis plants unfazed by hurricane, resume production

cafead

Administrator
Staff member
  • cafead   Sep 17, 2018 at 03:22: PM
via Drug manufacturers were shaking off the remnants of Hurricane Florence today as the dangers from the “monstrous” storm morphed into dangerous flooding.

GlaxoSmithKline, Pfizer and Novartis and Novo Nordisk all confirmed their manufacturing operations were back online.

article source